Electronic Drug Delivery Systems Market

Electronic drug delivery systems (EDDS) represents an exciting trend in the development of drug delivery systems that are portable, interactive, wirelessly connected and allow patient-administered therapy reducing overall healthcare cost.

Electronic Drug Delivery Systems Market contains market size and forecasts of Electronic Drug Delivery Systems in global, including the following market information:

Global Electronic Drug Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Electronic Drug Delivery Systems Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Electronic Drug Delivery Systems companies in 2021 (%)

The global Electronic Drug Delivery Systems market was valued at 9151.7 million in 2021 and is projected to reach US$ 14090 million by 2028, at a CAGR of 6.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Electronic Wearable Infusion Pumps Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Electronic Drug Delivery Systems include Medtronic, Novo Nordisk, Insulet, Bayer, United Therapeutics, AstraZeneca, Tandem Diabetes Care, Merck and Amgen. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Electronic Drug Delivery Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Electronic Drug Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Electronic Drug Delivery Systems Market Segment Percentages, by Type, 2021 (%)

Electronic Wearable Infusion Pumps

Electronic Autoinjectors

Electronic Injection Pens

Electronic Inhalers

Global Electronic Drug Delivery Systems Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Electronic Drug Delivery Systems Market Segment Percentages, by Application, 2021 (%)

Diabetes

Multiple Sclerosis

Cardiovascular Disease

Asthma & COPD

Other Indications

Global Electronic Drug Delivery Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Electronic Drug Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Electronic Drug Delivery Systems revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Electronic Drug Delivery Systems revenues share in global market, 2021 (%)

Key companies Electronic Drug Delivery Systems sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Electronic Drug Delivery Systems sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Medtronic

Novo Nordisk

Insulet

Bayer

United Therapeutics

AstraZeneca

Tandem Diabetes Care

Merck

Amgen